Skip to content

New way to treating the smile lines

The evaluation of efficacy and adverse effects of subcision in the correction of nasolabial fold

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201108097270N1
Enrollment
10
Registered
2012-01-27
Start date
2012-02-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

improvement of nasolabial fold by subcision. Procedure for purposes other than remedying health state, unspecified

Interventions

At first, the desired area is marked and local anesthesia is undergone using lidocain 1%. The subcision needle penetrates the skin from the margin of the nasolabial fold while its sharp edge is upward
Treatment - Surgery

Sponsors

Skin research center, Shohada-e-Tajrish hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. age 30-60y; 2.deep nasolabial fold. Exclusion criteria:1.age under 30y; 2.lactation & pregnancy; 3.history of coagulopathy or use of anticouagulant drug; 4.active infection in facial zone; 5.inability to stay in the study; 6.history of collagen or elastin disorder and connective tissue disease; 7.history of facial skin cancer; 8.history of topical medication administration during 1 month before study except sunscreen; 9.history of cosmetic procedure during last year (laser,..); 10. history of filler injection in nasolabial fold during last 5 years.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nasolabial fold. Timepoint: before treatment,1 w, 1 m and 6 m after treatment. Method of measurement: photograph,reviscometer.

Secondary

MeasureTime frame
Bleeding. Timepoint: immediately after treatment and the day after. Method of measurement: observation.;Ecchymosis. Timepoint: 2 hours ,1 day and 1 week after treatment. Method of measurement: observation.;Infection. Timepoint: 1 w after treatment. Method of measurement: physical exam.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Mahmoud Robati

Skin Research Center, Shahid Beheshti University of Medical Sciences

robati@razi.tums.ac.ir+98 21 2274 1507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 5, 2026